Aida Pharmaceuticals is trading at 2.0E-4 as of the 19th of January 2025, a No Change since the beginning of the trading day. The stock's open price was 2.0E-4. Aida Pharmaceuticals has more than 60 % chance of experiencing financial distress in the next few years of operation. It also did not have a very good performance during the last 90 trading days. The performance scores are derived for the period starting the 20th of December 2024 and ending today, the 19th of January 2025. Click here to learn more.
Aida Pharmaceuticals, Inc., together with its subsidiaries, engages in the formulation, clinical testing, registration, manufacture, sales, and marketing of pharmaceutical and genetic products in mainland China. Aida Pharmaceuticals, Inc. was founded in 1999 and is headquartered in Hangzhou, China. More on Aida Pharmaceuticals
Aida Pharmaceuticals [AIDA] is a Pink Sheet which is traded between brokers over the counter. The company currently falls under 'Nano-Cap' category with a current market capitalization of 8.37 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Aida Pharmaceuticals's market, we take the total number of its shares issued and multiply it by Aida Pharmaceuticals's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Aida Pharmaceuticals conducts business under Healthcare sector and is part of Drug Manufacturers—Specialty & Generic industry.
Aida Pharmaceuticals currently holds about 8.28 M in cash with 8.39 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.31, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Check Aida Pharmaceuticals Probability Of Bankruptcy
Our tools can tell you how much better you can do entering a position in Aida Pharmaceuticals without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.
Did you try this?
Run Watchlist Optimization Now
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Aida Pharmaceuticals financial ratios help investors to determine whether Aida Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Aida with respect to the benefits of owning Aida Pharmaceuticals security.